SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-001093
Filing Date
2024-02-16
Accepted
2024-02-16 17:51:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3309
  Complete submission text file 0001950047-24-001093.txt   4877
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40431 | Film No.: 24649837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 395 OYSTER POINT BLVD. SUITE 217 SOUTH SAN FRANCISCO CA 94080
Business Address
Bender Jeremy (Reporting) CIK: 0001863107 (see all company filings)

Type: 144